Zhenghong Wang - Biostar Pharmaceuticals Chief Officer
| BSPMDelisted Stock | USD 0.01 0.00 0.00% |
Executive
Mr. Zhenghong Wang is Chief Operating Officer of Biostar Pharmaceuticals Inc., since March 2012. From 2001 until now he has served in various capacities at Aoxing Pharmaceutical including accountant, recruiting manager, sales manager, marketing director in charge of Guizhou Province. Mr. Wang graduated from Shaanxi Professional Financial Technology College in 2001. since 2012.
| Age | 43 |
| Tenure | 12 years |
| Phone | 86 29 3368 6638 |
| Web | https://biostarpharmaceuticals.com |
Biostar Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.0425 % which means that it generated a profit of $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0266 %, meaning that it created $0.0266 on every $100 dollars invested by stockholders. Biostar Pharmaceuticals' management efficiency ratios could be used to measure how well Biostar Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Matt Augustson | Lifecore Biomedical | N/A | |
| Jackie Klecker | Lifecore Biomedical | N/A | |
| Jon Knight | Kamada | 58 | |
| Mike Nanfito | Ironwood Pharmaceuticals | N/A | |
| Boris Gorelik | Kamada | 43 | |
| Steve Laninga | Lifecore Biomedical | N/A | |
| Jean Marstiller | Cumberland Pharmaceuticals | 74 | |
| Ronald Silver | Ironwood Pharmaceuticals | 41 | |
| Timothy CPA | Shuttle Pharmaceuticals | 66 | |
| Marcel Moulaison | Ironwood Pharmaceuticals | N/A | |
| Greg Martini | Ironwood Pharmaceuticals | N/A | |
| Shavit Beladev | Kamada | N/A | |
| Liron Reshef | Kamada | 53 | |
| Jana Noeldeke | Ironwood Pharmaceuticals | N/A | |
| Brikkelle Thompson | Lifecore Biomedical | N/A | |
| Andrew Davis | Ironwood Pharmaceuticals | 38 | |
| Hanni Neheman | Kamada | 54 | |
| Amir London | Kamada | 55 | |
| Chris Bitterman | Cumberland Pharmaceuticals | 59 | |
| Erin Gull | Cumberland Pharmaceuticals | N/A | |
| Chaime Orlev | Kamada | 54 | |
Management Performance
| Return On Equity | 0.0266 | ||||
| Return On Asset | 0.0425 |
Biostar Pharmaceuticals Leadership Team
Elected by the shareholders, the Biostar Pharmaceuticals' board of directors comprises two types of representatives: Biostar Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biostar. The board's role is to monitor Biostar Pharmaceuticals' management team and ensure that shareholders' interests are well served. Biostar Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biostar Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zhenghong Wang, Chief Officer | ||
| Pr Zheng, Chief Scientist | ||
| Ronghua Wang, Chairman, CEO and President Chairman of Aoxing Pharmaceutical Inc, CEO of Aoxing Pharmaceutical Inc and President of Aoxing Pharmaceutical Inc | ||
| Xiaojuan Zhai, Chief Officer | ||
| Shuang Gong, Secretary of Board |
Biostar Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Biostar Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0266 | ||||
| Return On Asset | 0.0425 | ||||
| Profit Margin | 2.94 % | ||||
| Operating Margin | 8.76 % | ||||
| Current Valuation | 316.46 K | ||||
| Shares Outstanding | 2.64 M | ||||
| Number Of Shares Shorted | 170.44 K | ||||
| Price To Book | 0.01 X | ||||
| Price To Sales | 0.0001 X | ||||
| Revenue | 317.79 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Biostar Pink Sheet
If you are still planning to invest in Biostar Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostar Pharmaceuticals' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |